[en] [en] BACKGROUND: In response to the pandemic, the International Hepato-Pancreato-Biliary Association (IHPBA) developed the IHPBA-COVID Registry to capture data on HPB surgery outcomes in COVID-positive patients prior to mass vaccination programs. The aim was to provide a tool to help members gain a better understanding of the impact of COVID-19 on patient outcomes following HPB surgery worldwide.
METHODS: An online registry updated in real time was disseminated to all IHPBA, E-AHPBA, A-HPBA and A-PHPBA members to assess the effects of the pandemic on the outcomes of HPB procedures, perioperative COVID-19 management and other aspects of surgical care.
RESULTS: One hundred twenty-five patients from 35 centres in 18 countries were included. Seventy-three (58%) patients were diagnosed with COVID-19 preoperatively. Operative mortality after pancreaticoduodenectomy and major hepatectomy was 28% and 15%, respectively, and 2.5% after cholecystectomy. Postoperative complication rates of pancreatic procedures, hepatic interventions and biliary interventions were respectively 80%, 50% and 37%. Respiratory complication rates were 37%, 31% and 10%, respectively.
CONCLUSION: This study reveals a high risk of mortality and complication after HPB surgeries in patient infected with COVID-19. The more extensive the procedure, the higher the risk. Nonetheless, an increased risk was observed across all types of interventions, suggesting that elective HPB surgery should be avoided in COVID positive patients, delaying it at distance from the viral infection.
Disciplines :
Surgery
Author, co-author :
Badrudin, David; HPB & Transplant Surgery, Assistant Professor of Surgery, Department of Surgery, Université de Montréal, Montreal, Canada
Lesurtel, Mickaël; Head of HPB Surgery & Liver Transplantation, Beaujon Hospital - University of Paris Cité, Paris, France
Shrikhande, Shailesh; Deputy Director and Head of Cancer Surgery, Tata Memorial Hospital, Mumbai, India
Gallagher, Tom; St. Vincent's University Hospital, Dublin, Ireland
The authorship as well as the different Research and Scientific Committees would like to express their gratitude towards all the participants for their contributions to this work:, M. Peters (executive director of IHPBA), Med Science Net, and all the contributors: S Curley, T. Georgiev-Hristov, R. Lozano-Salazar, N. Jamieson, N. Bayramov, M. Al-Shehari, P. Antonakis, D. Barzallo, A. Taibi, A. Adeyeye, A. Coker, A. Gupta, A. Kazemi Nava, F. Alconchel, G. Stavrou, J. Ferreres Serafini, J-L. Beristain-Hernandez.
Deng, X., Yang, J., Wang, W., Wang, X., Zhou, J., Chen, Z., et al. Case fatality risk of novel coronavirus diseases 2019 in China. 2020, medRxiv.
WorldHealthOrganization. Statement on the COVID-19 situation in Europe. 2020 May 12 [Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/statements/statement-on-the-covid-19-situation-in-europe.
Torzilli, G., Vigano, L., Galvanin, J., Castoro, C., Quagliuolo, V., Spinelli, A., et al. A snapshot of elective oncological surgery in Italy during COVID-19 emergency: pearls, pitfalls, and perspectives. Ann Surg 272 (2020), e112–e117.
Balakrishnan, A., Lesurtel, M., Siriwardena, A.K., Heinrich, S., Serrablo, A., Besselink, M.G.H., et al. Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey. HPB 22 (2020), 1128–1134.
Polak, W.G., Fondevila, C., Karam, V., Adam, R., Baumann, U., Germani, G., et al. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European liver and intestine transplantation association and European liver transplant registry. Transpl Int 33 (2020), 1244–1252.
Abu Jawdeh, B.G., COVID-19 in kidney transplantation: outcomes, immunosuppression management, and operational challenges. Adv Chron Kidney Dis 27 (2020), 383–389.
Collaborative, C.O., Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 396 (2020), 27–38.
Gupta, R., Gupta, J., Ammar, H., Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol 14 (2021), 932–946.
Khonsari, R.H., Bernaux, M., Vie, J.J., Diallo, A., Paris, N., Luong, L.B., et al. Risks of early mortality and pulmonary complications following surgery in patients with COVID-19. Br J Surg 108 (2021), e158–e159.
Lei, S., Jiang, F., Su, W., Chen, C., Chen, J., Mei, W., et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine, 21, 2020, 100331.
Coccolini, F., Perrone, G., Chiarugi, M., Di Marzo, F., Ansaloni, L., Scandroglio, I., et al. Surgery in COVID-19 patients: operational directives. World J Emerg Surg, 15, 2020, 25.
Kibbe, M.R., Surgery and COVID-19. JAMA 324 (2020), 1151–1152.
Moletta, L., Pierobon, E.S., Capovilla, G., Costantini, M., Salvador, R., Merigliano, S., et al. International guidelines and recommendations for surgery during Covid-19 pandemic: a Systematic Review. Int J Surg 79 (2020), 180–188.
Kneuertz, P.J., Pitt, H.A., Bilimoria, K.Y., Smiley, J.P., Cohen, M.E., Ko, C.Y., et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg 16 (2012), 1727–1735.
Muscari, F., Suc, B., Kirzin, S., Hay, J.M., Fourtanier, G., Fingerhut, A., et al. Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 139 (2006), 591–598.
Yeo, C.J., Cameron, J.L., Sohn, T.A., Lillemoe, K.D., Pitt, H.A., Talamini, M.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997), 248–257 discussion 57-60.
Regimbeau, J.M., Kianmanesh, R., Farges, O., Dondero, F., Sauvanet, A., Belghiti, J., Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131 (2002), 311–317.
Shim, J.R., Lee, S.D., Park, H.M., Lee, E.C., Park, B., Han, S.S., et al. Outcomes of liver resection in patients with colorectal liver metastases by laparoscopic or open surgery. Ann Hepatobiliary Pancreat Surg 22 (2018), 223–230.
Carrier, F.M., Amzallag, E., Lecluyse, V., Cote, G., Couture, E.J., D'Aragon, F., et al. Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study. BMC Anesthesiol, 21, 2021, 15.
Knisely, A., Zhou, Z.N., Wu, J., Huang, Y., Holcomb, K., Melamed, A., et al. Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures. Ann Surg 273 (2021), 34–40.
Aziz, H., Filkins, A., Kwon, Y.K., Review of COVID-19 outcomes in surgical patients. Am Surg 86 (2020), 741–745.
Sharma, P., Chen, V., Fung, C.M., Troost, J.P., Patel, V.N., Combs, M., et al. COVID-19 outcomes among solid organ transplant recipients: a case-control study. Transplantation 105 (2021), 128–137.
Belli, L.S., Fondevila, C., Cortesi, P.A., Conti, S., Karam, V., Adam, R., et al. Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with covid-19: results from the ELITA/ELTR multi-center European study. Gastroenterology 160 (2021), 1151–11563 e3.
Booth, A., Reed, A.B., Ponzo, S., Yassaee, A., Aral, M., Plans, D., et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS One, 16, 2021, e0247461.
Bertsimas, D., Lukin, G., Mingardi, L., Nohadani, O., Orfanoudaki, A., Stellato, B., et al. COVID-19 mortality risk assessment: an international multi-center study. PLoS One, 15, 2020, e0243262.
Weiss, P., Murdoch, D.R., Clinical course and mortality risk of severe COVID-19. Lancet 395 (2020), 1014–1015.
Alizadehsani, R., Alizadeh Sani, Z., Behjati, M., Roshanzamir, Z., Hussain, S., Abedini, N., et al. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol 93 (2021), 2307–2320.
Dessie, Z.G., Zewotir, T., Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis, 21, 2021, 855.
Kim, L., Garg, S., O'Halloran, A., Whitaker, M., Pham, H., Anderson, E.J., et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-Associated hospitalization surveillance network (COVID-NET). Clin Infect Dis 72 (2021), e206–e214.
Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M.H., Sarraf, P., Djalali, M., Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male 23 (2020), 1416–1424.
Coimbra, R., Edwards, S., Kurihara, H., Bass, G.A., Balogh, Z.J., Tilsed, J., et al. European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID-19 infection. Eur J Trauma Emerg Surg 46 (2020), 505–510.
Collaborative, C.O., GlobalSurg, C., Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 76 (2021), 748–758.
El-Boghdadly, K., Cook, T.M., Goodacre, T., Kua, J., Blake, L., Denmark, S., et al. SARS-CoV-2 infection, COVID-19 and timing of elective surgery: a multidisciplinary consensus statement on behalf of the association of anaesthetists, the centre for peri-operative care, the federation of surgical specialty associations, the royal college of anaesthetists and the royal college of surgeons of england. Anaesthesia 76 (2021), 940–946.
Collaborative, C.O., GlobalSurg, C., Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia 76 (2021), 1454–1464.
Kovoor, J.G., Scott, N.A., Tivey, D.R., Babidge, W.J., Scott, D.A., Beavis, V.S., et al. Proposed delay for safe surgery after COVID-19. ANZ J Surg 91 (2021), 495–506.
SocietyofSurgicalOncology(SSO). Resource for management options of GI and HPB cancers. 2020 [Available from: https://www.surgonc.org/wp-content/uploads/2020/03/GI-and-HPB-Resource-during-COVID-19-3.23.20.pdf.
Hanna, T.P., King, W.D., Thibodeau, S., Jalink, M., Paulin, G.A., Harvey-Jones, E., et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ, 371, 2020, m4087.
Vasilyeva, E., Li, J., Desai, S., Chung, S.W., Scudamore, C.H., Segedi, M., et al. Impact of surgical wait times on oncologic outcomes in resectable pancreas adenocarcinoma. HPB 22 (2020), 892–899.
Lim, C., Bhangui, P., Salloum, C., Gomez-Gavara, C., Lahat, E., Luciani, A., et al. Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma. J Hepatol 68 (2017), 100–108.
Bennett, S., Soreide, K., Gholami, S., Pessaux, P., Teh, C., Segelov, E., et al. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 27 (2020), e501–e511.
Finley, C., Prashad, A., Camuso, N., Daly, C., Aprikian, A., Ball, C.G., et al. Guidance for management of cancer surgery during the COVID-19 pandemic. Can J Surg 63 (2020), S2–S4.
Prasad, N.K., Lake, R., Englum, B.R., Turner, D.J., Siddiqui, T., Mayorga-Carlin, M., et al. COVID-19 vaccination associated with reduced postoperative SARS-CoV-2 infection and morbidity. Ann Surg 275 (2022), 31–36.
Covidsurg Collaborative, G.C., SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg 108 (2021), 1056–1063.
Challen, R., Brooks-Pollock, E., Read, J.M., Dyson, L., Tsaneva-Atanasova, K., Danon, L., Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ, 372, 2021, n579.
